Inflammatory Markers in Saliva for Diagnosis of Sepsis of Hospitalizes Patients
Overview
Authors
Affiliations
Background: Inflammatory/immunological serum markers are useful for the early detection of organ dysfunction, helping the diagnosis of sepsis. Although the detection of blood biomarkers is a standard practice, the use of noninvasive samples (eg saliva) would be beneficial.
Aim: To investigate the saliva of hospitalized patients with and without sepsis and identify the levels of inflammatory markers such as C-reactive protein (CRP), procalcitonin (PCT), interleukin 6 (IL-6) and nitric oxide (NO).
Methods: Saliva samples were collected from 26 patients in intensive care unit with diagnosis of sepsis and from 26 without sepsis (control). The levels of CRP were determined by using latex agglutination test, whereas those of procalcitonin and IL-6 by ELISA and NO by the Griess reaction.
Results: Of 26 patients with sepsis, 14 were males (54%) with a mean age of 63.81 ± 3.48 years. The control group had the same distribution for gender, with mean age 65.04 ± 4.07 years. Sepsis group showed higher salivary concentrations of CRP, PCT, IL-6 and NO, with only levels of IL-6 being statistically different (P = .0001).
Conclusions: Patients with sepsis had significantly higher levels of IL-6 in their saliva, suggesting that this biological sample could be useful in the diagnosis of this condition.
Shim J, Muraru S, Dobrota R, Fleisch E, Distler O, Barata F JMIR Res Protoc. 2024; 13:e62877.
PMID: 39499914 PMC: 11576606. DOI: 10.2196/62877.
Performance and overview of clinically relevant areas of application of saliva testing in the cat.
Schroers M, Meyer-Lindenberg A Front Vet Sci. 2024; 11:1385345.
PMID: 38840640 PMC: 11150842. DOI: 10.3389/fvets.2024.1385345.
Proteomic Investigation of COVID-19 Severity During the Tsunamic Second Wave in Mumbai.
Rajoria S, Nair D, Suvarna K, Pai M, Salkar A, Palanivel V Adv Exp Med Biol. 2023; 1412:175-195.
PMID: 37378767 DOI: 10.1007/978-3-031-28012-2_9.
Salivary biomarkers in COVID-19 patients.
Ubhale R, Dahake S, Madhu P, Gaurav Chhabra K, Reche A, Bankar A J Family Med Prim Care. 2023; 11(11):6778-6782.
PMID: 36992999 PMC: 10041187. DOI: 10.4103/jfmpc.jfmpc_1569_21.
Ramavath C, Katam S, Vardhelli V, Deshabhotla S, Oleti T Diagnostics (Basel). 2023; 13(5).
PMID: 36900011 PMC: 10000952. DOI: 10.3390/diagnostics13050867.